M. Hrudková

Significant change in ZAP‐70 expression during the course of chronic lymphocytic leukemia

J. Krejsek, F. Vrbacky, L. Smolej, 2010, European journal of haematology.

Addition of Rituximab Significantly Improves Outcomes in Patients with Diffuse Large B-cell Lymphoma - a Single-center, Retrospective Study.

P. Žák, D. Belada, P. Štěpánková, 2007, Acta medica.

Biological Prognostic Markers in Chronic Lymphocytic Leukemia.

J. Krejsek, F. Vrbacky, L. Smolej, 2009, Acta medica.

[Primary central nervous system lymphomas].

James V. Leonard, A. L. Wong, I. Módy, 2010, Vnitrni lekarstvi.

Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features

M. Červinka, J. Krejsek, F. Vrbacky, 2010, Hematology.

Rituximab In Combination with High-Dose Dexamethasone: An Effective Treatment Option for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

M. Šimkovič, M. Doubek, D. Belada, 2010 .